metatensin #2

Frequently asked questions

How is Metatensin #2 rated?

pharmaranks gives Metatensin #2 a composite score of 3.5 out of 5, currently based on 1 weighted source (FDA regulatory recall-safety data weighted highest). See our methodology at /how-we-rate.

Is there a coupon or discount for Metatensin #2?

pharmaranks is an independent ratings site, not a pharmacy — we don't issue coupons or sell Metatensin #2. To pay less, ask your prescriber or pharmacist whether a generic equivalent exists, check the manufacturer's copay/savings card and patient-assistance program, and compare a pharmacy discount card against your insurance copay. Prices vary by pharmacy, insurance, and location, so always confirm at the counter. This is general reference, not medical or financial advice.

Who makes Metatensin #2?

Metatensin #2 is marketed by Sanofi Aventis US. You can see Sanofi Aventis US's full profile, rating, and other products on pharmaranks.

Is Metatensin #2 a brand-name or generic drug?

Metatensin #2 is a brand-name product with the active ingredient Reserpine and Trichlormethiazide.

Is Metatensin #2 available over the counter?

No. Metatensin #2 is a prescription (Rx) medication in the US — you need a prescription from a licensed clinician (in person or via telehealth); it isn't sold over the counter. For some conditions there are OTC alternatives — ask your pharmacist.

What forms does Metatensin #2 come in?

Metatensin #2 is currently marketed as tablet, per the FDA's National Drug Code Directory.

Is Metatensin #2 FDA-registered?

Metatensin #2 is on record with the U.S. FDA under application number NDA012972. You can verify this on its official FDA label.

Has Metatensin #2 been recalled by the FDA?

Metatensin #2 has no FDA recalls recorded under its own application in the openFDA enforcement database. Its recall-safety score reflects its manufacturer's overall recall record. This is general reference, not medical advice — check the FDA recall database for the latest alerts.

Is Metatensin #2 safe?

There's no single safe-or-not verdict. pharmaranks gives Metatensin #2 a recall-safety score of 70/100, based on its FDA recall history (no recalls under its own FDA application) — not an efficacy or side-effect rating. Review its FDA-label side effects and warnings before use, and always consult a licensed professional.